ArticleDrugs in context2026

Real-life effectiveness and safety of bimekizumab in patients with moderate plaque psoriasis: a 54-week multicentre study in the Lazio region.

Francesca Feresin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.